Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,127Revenue (TTM) $M473Net Margin (%)15.9Altman Z-Score1.6
Enterprise Value $M1,943EPS (TTM) $2.0Operating Margin %32.0Piotroski F-Score4
P/E(ttm)15.3Beneish M-Score1.8Pre-tax Margin (%)23.8Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %77.0Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow8.3y-y EBITDA Growth Rate %-21.8ROA % (ttm)7.5Higher Current Ratio y-yN
Dividend Yield %--PEG0.2ROE % (ttm)15.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M36.8ROIC % (ttm)14.4Gross Margin Increase y-yN

Gurus Latest Trades with LCI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LCIRonald Muhlenkamp 2016-03-31 Buy 2.98%$17.23 - $40.12
($26.78)
$ 30.6715%New holding406,600
LCIJoel Greenblatt 2016-03-31 Sold Out -0.49%$17.23 - $40.12
($26.78)
$ 30.6715%Sold Out0
LCIDavid Dreman 2016-03-31 Buy $17.23 - $40.12
($26.78)
$ 30.6715%New holding70
LCIJoel Greenblatt 2015-12-31 Reduce-0.11%$34.38 - $48.3
($40.96)
$ 30.67-25%Reduce -19.76%1,121,673
LCIDavid Dreman 2015-12-31 Sold Out $34.38 - $48.3
($40.96)
$ 30.67-25%Sold Out0
LCIJoel Greenblatt 2015-09-30 Reduce-0.16%$41.52 - $62.74
($54.88)
$ 30.67-44%Reduce -19.11%1,397,853
LCIDavid Dreman 2015-09-30 Buy $41.52 - $62.74
($54.88)
$ 30.67-44%New holding367
LCIJoel Greenblatt 2015-06-30 Add0.09%$52.6 - $71.15
($60.12)
$ 30.67-49%Add 11.07%1,728,019
LCIJoel Greenblatt 2015-03-31 Add0.27%$41.29 - $69.82
($56.77)
$ 30.67-46%Add 51.63%1,555,795
LCIJoel Greenblatt 2014-12-31 Add0.25%$40.3 - $57.52
($46.48)
$ 30.67-34%Add 238.24%1,026,029
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
($39.77)
$ 30.67-23%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
($39.16)
$ 30.67-22%New holding35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ehlinger RobertVP and CIO 2016-06-23Sell37,141$25.0622.39view
Ehlinger RobertVP and CIO 2016-06-20Sell62,859$25.420.75view
Ehlinger RobertVP of Logistics and CIO 2016-03-01Sell69,247$25.4120.7view
PAONESSA ALBERT IIIDirector 2016-02-05Buy2,500$24.5724.83view
GALVAN MARTIN PVP of Finance & CFO 2016-02-05Buy3,000$24.6524.42view
Taveira PaulDirector 2016-02-05Buy1,000$23.629.96view
Maher James M.Director 2016-02-05Buy1,000$23.8728.49view
FARBER JEFFREYDirector 2016-02-05Buy5,000$24.4825.29view
Drabik David ADirector 2016-02-05Buy1,277$24.7423.97view
SMITH KEVINVP of Sales and Marketing 2016-02-05Buy1,500$24.7523.92view

Quarterly/Annual Reports about LCI:

News about LCI:

Articles On GuruFocus.com
Snow Capital Management's Top 5 New Buys May 12 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Healthcare Company Lannett Offers Compelling Value Oct 13 2015 
Royce 100 Fund Shareholder Letter Sep 20 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 
Lannett Company Inc Reports Operating Results (10-Q) Nov 12 2010 
Lannett Company Inc Reports Operating Results (10-K) Sep 24 2010 
Lannett Company Inc Reports Operating Results (10-Q) May 13 2010 
Lannett Company Inc Reports Operating Results (10-Q) Feb 11 2010 

More From Other Websites
Fracking Sand Among Market Hot Spots Jul 21 2016
Lannett Gets FDA Acceptable Filing Letter For Fentanyl Patch ANDA Jul 20 2016
Lannett Announces Receipt Of FDA Acceptable Filing Letter For Fentanyl Patch ANDA Jul 20 2016
Sagent Pharma Sells For $736 Million; Lannett Jumps On Drug Nod Jul 11 2016
Why NVIDIA, GoPro, Lannett Company and 2 Other Stocks Are Gaining Ground Today Jul 11 2016
Lannett Co. (LCI) Gets FDA Approval, Stock Soars 10.5% Jul 11 2016
Lannett Gets FDA Approval To Launch Paroxetine Extended Release Tablets Jul 11 2016
Lannett Announces Approval And Launch Of Paroxetine Extended Release Tablets USP, 12.5 Mg, 25 Mg,... Jul 11 2016
Lannett Announces Approval And Launch Of Paroxetine Extended Release Tablets USP, 12.5 Mg, 25 Mg,... Jul 11 2016
Coverage initiated on Lannett by Deutsche Bank Jun 29 2016
Lannett Receives FDA Approval For Diazepam Oral Solution, 5 mg/5 mL Jun 28 2016
Lannett Receives FDA Approval For Diazepam Oral Solution, 5 mg/5 mL Jun 28 2016
LANNETT CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jun 20 2016
Lannett Completes Repurchase Of Remaining $200 Million Of 12% Senior Notes Jun 20 2016
Lannett Completes Repurchase Of Remaining $200 Million Of 12% Senior Notes Jun 20 2016
$200M buyback: Lannett wiping more high-interest debt off its balance sheet Jun 14 2016
Lannett To Amend Credit Agreement To Repurchase Remaining $200 Million Of 12% Senior Notes Jun 14 2016
Lannett To Amend Credit Agreement To Repurchase Remaining $200 Million Of 12% Senior Notes Jun 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)